Bioprocessing Analytics Equipment Market revenue is set to total USD 485.1 Million in 2022. The global market is expected to reach USD 633.6 Million by 2028, rising at a CAGR of 4.5%.
| Attribute | Details |
|---|---|
| Global Bioprocessing Analytics Equipment Market Size (2022) | USD 485.1 million |
| Predicted Market Value (2028) | USD 633.6 million |
| Forecasted Growth Rate (2022 to 2028) | 4.3% CAGR |
| Region with Highest Market Share | North America - 25.3% |
Bioprocessing analytics equipment demand accounts for 2.7% of the global biopharmaceutical equipment market. High demand for pharmaceutical manufacturing is expected to favour bioprocessing analytics equipment consumption over the forecast period.
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
| Particulars | Details |
|---|---|
| H1, 2021 | 4.54% |
| H1, 2022 Projected | 4.55% |
| H1, 2022 Outlook | 4.45% |
| BPS Change - H1, 2022 (O) – H1, 2022 (P) | (-) 10 ↓ |
| BPS Change – H1, 2022 (O) – H1, 2021 | (-) 09 ↓ |
As per the analysis by Future Market Insights, the variation between the BPS values observed within this market in H1, 2022 - outlook over H1, 2022 projected reflects a decline by 10 BPS. A decline in BPS growth in H1-2022 over H1-2021 by 09 Basis Point Share (BPS) is also demonstrated by the bioprocessing analytics equipment market.
The decline in the BPS values observed was attributed to the overall halt in the production and manufacturing capabilities during the mass lockdown impositions upon the advent of the global COVID-19 pandemic.
Conversely, through considerations in cost reduction during processes, consolidated bioprocessing approaches along with artificial intelligence and microfluidics are set to propel the process development in bioprocessing, thus promoting the growth of the overall industry.
The market is highly influenced by contract manufacturing dynamics, regulatory approvals, and licencing of therapeutics and biologics, under the impact of macro and industry factors. Key developments in the market include the development of Single-Use Systems (SUS) for bioprocessing, and bioremediation approaches for environmental sustainability.
Biomedical and biopharmaceutical industries have evolved exponentially over the past few years and increasing focus on creating better healthcare and medical ecosystem are expected to favor the demand for bioprocessing analytics equipment.
The market was valued at USD 337 Million and sales of bioprocessing analytics equipment rose at a CAGR of 4.1% for the market to attain a net valuation of USD 463.2 Million.
Rising demand for biotherapeutics, increasing demand for process optimization, rapid technological advancements, increasing research and development magnitude, and increasing scope of application in drug development and tissue engineering are some major factors that are expected to propel shipments of bioprocessing analytics equipment.
High cost of bioprocessing analytics equipment is expected to emerge as a major constraint in the global bioprocessing analytics equipment industry landscape. The demand for bioprocessing analytics equipment is projected to rise at a CAGR of 4.5% from 2022 to 2028.
Increasing R&D and Drug Approvals to Fuel Market Growth Potential
Research & development has seen an exponential increase over the past few years as the approval of new drugs has been increased by regulatory authorities such as the FDA (USA Food and Drug Administration). Increasing demand for the speedy development of new drugs and therapies has acted in favor of bioprocessing analytics equipment sales.
Increased research & development activity has encouraged bioprocessing analytics equipment manufacturers to launch new products to meet the increasing demand across the globe.
Since bioreactors have now become a staple in the bioprocessing industry, many companies have been rolling out new ones with larger capacities. The new bioreactors launched by Thermo Fisher are of capacities of 3000 liters and 5000 liters.
High Costs and Stringent Regulatory Standards Majorly Hinder Market Growth
High costs associated with bioprocessing analytics equipment are anticipated to be a major restraining factor in the global bioprocessing analytics equipment industry landscape. High costs restrict bioprocessing analytics equipment sales in less developed economies where spending potential is less.
Moreover, maintenance costs of bioprocessing analytics devices are also high which makes it even harder to afford while maintaining a budget for research and manufacturing operations.
Stringent regulatory norms and standards across the world make it difficult for bioprocessing analytics equipment manufacturers to create an evenly priced and distributed product for all. Which in turn creates an expensive product that is compliant with the standards of certain regions and countries. These factors are expected to restrain bioprocessing analytics equipment market potential.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
Increasing Focus on Healthcare to Drive Global Market Potential
The bioprocessing analytics equipment industry analysis details the market stance across multiple regions such as North America, Latin America, Europe, East Asia, South Asia & Pacific, and the Middle East & Africa (MEA).
Sales of bioprocessing analytics equipment in North America account for a dominant market share of 25.3% in 2022. Presence of key bioprocessing analytics equipment companies and advanced facilities in the region are expected to propel bioprocessing analytics system demand through 2028.
Increasing instances of diseases in Europe have led to a rise in research and development activities in the region which subsequently drives bioprocessing analytics equipment sales. The market for bioprocessing analytics equipment in Western Europe and Eastern Europe currently accounts for 21.5% and 5.4% of the global landscape.
On a cumulative note, East Asia, South Asia, and the Pacific regions are anticipated to see notable growth in bioprocessing analytics equipment market potential over the forecast period. Increased focus on healthcare and rising research on biotherapeutics and other pharmaceutical applications in emerging economies such as India and China is expected to drive market expansion in the aforementioned regions.
Demand for bioprocessing analytics equipment in the MEA region is predicted to rise at a steady pace as focus on healthcare increases and investments towards R&D activities increase in the region. Bioprocessing analytics system shipments in the MEA region account for 6.4% share of the global marketplace.
Increasing Focus on Healthcare and Biotherapeutics to Favour Market Growth
India provides an extremely lucrative setting for bioprocessing analytics equipment manufacturers as the nation has opportunities for manufacturing as well as distribution at very low costs compared to most developed nations. Government initiatives to attract foreign investments make India a lucrative manufacturing market for bioprocessing analytics equipment suppliers.
Rising focus on healthcare and a developing healthcare infrastructure fuel the demand for R&D activities which in turn increase bioprocessing analytics equipment sales.
Rising Healthcare Expenditure to Fuel Demand for Bioprocessing Analytics Equipment
The USA is one of the most prominent markets for bioprocessing analytics equipment in the world. The presence of major bioprocessing analytics equipment companies in this country is an extremely important factor that influences the consumption of bioprocessing analytics equipment.
Advanced healthcare infrastructure, high healthcare expenditure and spending, high availability of advanced facilities and technologies, high production of biotherapeutics are some major factors that propel bioprocessing analytics device sales in this nation.
Bioprocessing Analytics Equipment in Industrial Applications Predicted to Have Dominant Outlook
Increase in demand for pharmaceutical products and rising need to enhance the manufacturing process are fueling the use of bioprocessing analytics equipment in industrial applications. Bioprocessing analytics equipment enables industries to enhance their manufacturing processes and eliminates the possibilities of error that are common in manual bioprocess monitoring techniques.
Demand for bioprocessing analytics equipment in clinical application is also expected to rise at a steady pace with increase in research and development activities across the world.
Bioprocessing analytics equipment manufacturers are investing in mergers and acquisitions to broaden their product offerings and boosts sales across multiple regions. Investments to develop advanced bioprocess monitoring equipment is expected to be a prominent trend as manual monitoring is prone to error and is very labour-intensive.
| Attribute | Details |
|---|---|
| Forecast Period | 2022 to 2028 |
| Historical Data Available for | 2013 to 2021 |
| Market Analysis | USD million for Value |
| Key Regions Covered | North America; Latin America; Europe; East Asia; South Asia & Pacific; Middle East & Africa (MEA) |
| Key Countries Covered |
United States, Canada, Brazil, Mexico, Germany, UK, France, Spain, Italy, China, Japan, South Korea, India, Indonesia, Malaysia, Singapore, Australia, New Zealand, Turkey, South Africa, and GCC Countries |
| Key Market Segments Covered | Product Type, Application, End User, Region |
| Key Companies Profiled | Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd. (Roche Diagnostics), ELITechGroup, KNAUER, Gonotec GmbH, Advanced Instruments Inc., Resolution Spectra Systems Inc., Kaiser Optical Systems Inc., SYSBIOTECH SARL |
| Pricing | Available upon Request |
The global bioprocessing analytics equipment market rose at a CAGR of 4.1% and ended up with a valuation of USD 463.2 Million in 2021.
The bioprocessing analytics equipment market in Japan accounts for a market share of 7.6% in the global bioprocessing analytics equipment industry.
Bioprocessing analytics equipment sales are estimated to be worth USD 633.6 Million by the end of 2028.
Bioprocessing analytics equipment consumption is anticipated to rise at a CAGR of 4.5% from 2022 to 2028.
In 2022, the global bioprocessing analytics equipment market holds a valuation of USD 485.1 Million.
| Market Value for 2024 | USD 21.1 million |
|---|---|
| Market Value for 2034 | USD 33.7 million |
| Market CAGR from 2024 to 2034 | 4.8% |
| Market Size (2023) | USD 1.73 billion |
|---|---|
| Market Size (2033) | USD 6.75 billion |
| Market CAGR (2023 to 2033) | 14.6% |
| Market Size (2023) | USD 25.9 Billion |
|---|---|
| Market Market Size (2033) | USD 106.1 Billion |
| Value CAGR (2023 to 2033) | 15.1% |
| Market Size (2022) | USD 7.75 billion |
|---|---|
| Market Size (2032) | USD 26.08 billion |
| Market CAGR (2022 to 2032) | 12.9% |
Explore Life Science & Biotechnology Insights
View Reports
Bioprocessing Analytics Equipment Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
